The societal impact of dementia and neurodegenerative (ND) conditions cannot be overstated. Alzheimer’s Disease (AD) alone is estimated to affect 7 million people in Europe at present, entailing consequences for individuals, their families, carers and healthcare services. - Read more
‍

Through the Innovative Health Initiative (IHI), the European Commission, together with several industry partners supports the CLAIMS (Clinical impact through AI-assisted MS care) project for almost 10 million euros. The project will run over the next 4 years to realize a (...) - Read more
‍

More than 350 collaborators gathered together during these 3 days, coming from all over the planet, and almost half of them being new to OHDSI, which proves the real uptake that OMOP is having in the Real World Data space. (...) - Read more
‍

The project will create a digital platform for precision medicine to improve the diagnosis and treatment of neurodegenerative disease and co-morbidities. The overriding objective is to assist clinicians with individualised decision support in the evaluation of patients with (...) - Read more
‍

In March 2023, the DARWIN EU® Coordination Centre (CC) launched its Open Call, providing an opportunity for healthcare data custodians to submit their interest in joining the DARWIN EU® initiative and data network (...) - Read more
‍

"Synapse has had a dynamic and central role in eTRANSAFE since its onset. As the managing partner, Synapse has participated in all the stages of the project from its (...) - Read more
‍

Montse Camprubí is the Community Manager of EHDEN, a European federated network creating an open science community in Europe that supports methods, tools, and skills that promote collaborative research, as well as advocates for the acceptance of Real World Data (...) - Read more
‍

The entire SYNAPSE team gathered in Barcelona for a special annual meeting to close the year. The session was very collaborative, and included several sessions with a summary of the year and the challenges ahead, plus different workshops to enhance team dynamics (...) - Read more
‍

On the last 27th – 28th of October, nearly 50 representatives of TransBioLine consortium met face-to-face in Barcelona for the first time after the pandemic to hold the 5th Consortium Meeting, a 2-day event organised by SYNAPSE (...) - Read more
‍

After nearly 25 years of experience working with complex research projects, Synapse is well aware of the importance of going beyond classical project management (...) - Read more
‍

On the 3-4 of October, we organised a successful HTx Forum and Expert Meeting 2022 in Barcelona where more than 40 HTA experts gathered for this 2-day event - Read more
‍

Mery Loor and Sandra Pla, our Project Managers and lead members of AMYPAD’s Project Management Office, played part of the plenary session ‘Management of year 6’ at (...) - Read more
‍

The IMI call itself was in a way acknowledging that the project-based structure in the IMI neurodegeneration field was suffering from fragmentation. Our contribution was to design an action that would effectively alleviate the problems derived from every project (...) - Read more
‍

We’re celebrating 14 years of continuous support to complex research and development of biomedical projects (...) - Read more
‍

Representatives of NEURONET partner organizations and members of its Scientific Coordination Committee (SCB) met last July 1st in Barcelona to compile and evaluate the (...) - Read more
‍

The first face-to-face meeting of the project since 2020 was held in Barcelona in June 2022, featuring the First Edition ofthe eTRANSAFE Awards (...) - Read more
‍

Last 20th – 21st June, more than 120 representatives of ERA4TB partners met in Madrid after 2 years with the occasion of the 5th Consortium Meeting, an event co-organised by (...) - Read more
‍

Inari Soininen, our Senior Project Manager, led twoplenary sessions providing an overview of dissemination highlights and projectclosing requirements (...) - Read more
‍

Sandra Pla, COO of Synapse Research Management Partners, participated on June 1 at the XV Conference of Biomedical Research Technology Platforms as a member of a round (...) - Read more
‍

The Erasmus MC has been contracted by the European Medicines Agency to establish the Coordination Centre for the Data Analysis and Real World Interrogation Network (...) - Read more
‍

The Health Europa Quarterly digital publication brings together a variety of voices in the healthcare arena to highlight the latest trends and most cutting-edge developments in European health and healthcare research and policy (...) - Read more
‍

The annual conference was heldvirtually (29th of November -1st of December 2021) under the motto “Resilience indementia: Moving beyond the COVID-19 pandemic” this week (...) - Read more
‍

Elena Del Rey, Head of Business Development and Services at SYNAPSE, participated on the 29th of November as a panelist in the networking session “European Business Projects: success stories”, organised in Madrid by Confederación Empresarial de Madrid (CEIM), and (...) - Read more
‍

The virtual webinar organized by Confederación Empresarial de Madrid (CEIM) and the community of Madrid, focused on European funding for projects on R+D+I in the healthcare (...) - Read more
‍

EHDEN announces the creations of a new legal entity, a not-for-profit incorporated in The Netherlands which objective will be to transition the project into a long-term, sustainable operation from 2024. The new legal entity will facilitate the developing ecosystem (...) - Read more
‍

The members of the Neuronet (Efficiently Networking European Neurodegeneration Research) programme are pleased to announce the launch of a pan-European Knowledge Base which brings together key information about the 18 projects of the Innovative Medicines (...) - Read more
‍

This year the 30th Alzheimer Europe Conference was hosted online from 20 to 22 October 2020. The Neuronet sessions held as part of the conference were designed to showcase the work of IMI neurodegeneration projects in key areas (data sharing and accessibility, working (...) - Read more
‍

HARMONY PLUS will build upon the success of HARMONY, which is currently using the power of Big Data to speed up the development of improved treatments and more effective (...) - Read more
‍

Our Scientific Coordination Board (also known as the SCB) plays a central role in determining how we direct our efforts. As leaders of IMI neurodegeneration projects, the SCB members bring wide-ranging scientific, clinical, R&D and computational expertise to the table, helping (...) - Read more‍

Horizon 2020 (H2020) is the biggest EU Research and Innovation programme with €77 billion of funding available over seven years (2014-2020). H2020 helps Europe to produce world-class science and makes it easier for the public and private sectors to work together in deploying (...) - Read more
‍

The ERA4TB (European Regimen Accelerator for Tuberculosis) project is a public-private initiative dedicated to the development of drugs against tuberculosis. (...) - Read more
‍

Understanding the effectiveness of influenza vaccinesis a priority for both public health experts and vaccine manufacturers. DRIVE is a public-private partnership initiative setup to (...) - Read more
‍

The Neuronet (Efficiently Networking European Neurodegeneration Research) communication team is proud to announce the launch of the official project website (...) - Read more
‍

NEURONET, the new Innovative Medicines Initiative (IMI) Coordination and Support Action (CSA) aiming to support and better integrate projects in the IMI Neurodegenerative (...) - Read more
‍

The Synapse team is delighted to announce the launch of a new Innovative Medicines Initiative project, the Translational Safety Biomarker Pipeline (TransBioLine) Project (...) - Read more
‍

The SYNAPSE team is delighted to announce the launch of a new Horizon 2020 project, the HTx Project, which will operate in Europe for the coming five years, 2019 – 2023.The overall objective of HTx is to create a framework for next generation Health Technology Assessment (...) - Read more
‍

This year SYNAPSE, on behalf of the IMI project ROADMAP, sponsors the eleventh edition of the Clinical Trials on Alzheimer’s Disease (CTAD) that will take place on October (...) - Read more
‍

Ten years ago Innovative Medicines Initiative Joint Undertaking (IMI-JU) was created as a unique public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) aiming to accelerate (...) - Read more
‍

SYNAPSE is celebrating its 10th anniversary this year. The company has been steadily growing in size, expertise and in the complexity of the projects it is involved in. The SYNAPSE Executive Committee is fully engaged in a reflection to take stock of what has been achieved (...) - Read more
‍

This year SYNAPSE, on behalf of the IMI project ROADMAP, sponsors the eleventh edition of the Clinical Trials on Alzheimer’s Disease (CTAD) that will take place on October (...) - Read more
‍

In the frame of its Social Programme, Synapse has sponsored the AFASAF, a non-profit association of families affected by Fetal Alcohol Spectrum Disorders (FASD) (...) - Read more
‍